Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray".
Glenmark Pharmaceuticals Limited Press Release Aug 20 2026
Filed with NSE · · 3 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Jul 31 2026
- Glenmark Pharmaceuticals Limited Press Release Jul 28 2026
- Glenmark Pharmaceuticals Limited Press Release Jul 21 2026
- Glenmark Pharmaceuticals Limited Press Release Jul 06 2026
- Glenmark Pharmaceuticals Limited Press Release Jul 02 2026
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Aug 21 2026
- Glenmark Pharmaceuticals and South Piedmont Community College Launch Aseptic Training Facility in Monroe, N.C.
- Glenmark Pharmaceuticals Limited Press Release Sep 23 2026
- Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 06, 2026, titled "Glenmark Therapeutics Inc., USA launches Pump Packs for Adapalene Gel USP, 0.1% (OTC)".
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals